OneMedNet advances commercial launch of Palantir Foundry-powered real-world data platform

Reuters
Feb 27
<a href="https://laohu8.com/S/ONMD">OneMedNet</a> advances commercial launch of <a href="https://laohu8.com/S/PLTR">Palantir</a> Foundry-powered real-world data platform

OneMedNet Corporation said it is entering the next phase of its commercial launch for its Real-World Data platform powered by Palantir Foundry, and is working to convert customer evaluations into paid subscriptions following a Nov. 10, 2025 demonstration of live feeds, subscription access and AI-driven search. The company reported early evaluation feedback citing analytical depth across integrated clinical and longitudinal datasets, faster cohort feasibility and discovery, streamlined workflows, and quicker onboarding of data partners. OneMedNet said it is expanding subscription contracts, including multi-year deals representing millions in incremental recurring revenue, and that its iRWD network now includes more than 2,130 healthcare sites. The company also said datasets on the platform are continuously connected to sources in real time, providing longitudinal access spanning more than 20 years of historical data and extending three years forward.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602270850PRIMZONEFULLFEED9662683) on February 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10